These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38556102)

  • 21. Self-assembly of virus-like particles of porcine circovirus type 2 capsid protein expressed from Escherichia coli.
    Yin S; Sun S; Yang S; Shang Y; Cai X; Liu X
    Virol J; 2010 Jul; 7():166. PubMed ID: 20646322
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Production of Escherichia coli-based virus-like particle vaccine against porcine circovirus type 2 challenge in piglets: Structure characterization and protective efficacy validation.
    Xi X; Mo X; Xiao Y; Yin B; Lv C; Wang Y; Sun Z; Yang Q; Yao Y; Xuan Y; Li X; Yuan YA; Tian K
    J Biotechnol; 2016 Apr; 223():8-12. PubMed ID: 26907669
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Generation in yeast of recombinant virus-like particles of porcine circovirus type 2 capsid protein and their use for a serologic assay and development of monoclonal antibodies.
    Nainys J; Lasickiene R; Petraityte-Burneikiene R; Dabrisius J; Lelesius R; Sereika V; Zvirbliene A; Sasnauskas K; Gedvilaite A
    BMC Biotechnol; 2014 Dec; 14():100. PubMed ID: 25487652
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Large-scale manufacture of VP2 VLP vaccine against porcine parvovirus in Escherichia coli with high-density fermentation.
    Wang J; Liu Y; Chen Y; Wang A; Wei Q; Liu D; Zhang G
    Appl Microbiol Biotechnol; 2020 May; 104(9):3847-3857. PubMed ID: 32130468
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A chimeric virus created by DNA shuffling of the capsid genes of different subtypes of porcine circovirus type 2 (PCV2) in the backbone of the non-pathogenic PCV1 induces protective immunity against the predominant PCV2b and the emerging PCV2d in pigs.
    Matzinger SR; Opriessnig T; Xiao CT; Catanzaro N; Beach NM; Slade DE; Nitzel GP; Meng XJ
    Virology; 2016 Nov; 498():82-93. PubMed ID: 27564544
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced Th1-biased immune efficacy of porcine circovirus type 2 Cap-protein-based subunit vaccine when coadministered with recombinant porcine IL-2 or GM-CSF in mice.
    Wang Y; Lu Y; Liu D; Wei Y; Guo L; Wu H; Huang L; Liu J; Liu C
    Appl Microbiol Biotechnol; 2015 Feb; 99(3):1155-63. PubMed ID: 25487886
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Construction and immunogenicity of recombinant porcine circovirus-like particles displaying somatostatin.
    Li W; Wang X; Bai J; Ma T; Li Z; Li Y; Jiang P
    Vet Microbiol; 2013 Apr; 163(1-2):23-32. PubMed ID: 23294858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunological characteristics of a recombinant alphaherpesvirus with an envelope-embedded
    Lu C; Li H; Chen W; Li H; Ma J; Peng P; Yan Y; Dong W; Jin Y; Pan S; Shang S; Gu J; Zhou J
    Front Immunol; 2024; 15():1438371. PubMed ID: 39081314
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunogenicity Evaluation of Modified Adenovirus Vaccines Expressing Porcine Circovirus Type 2 Capsid Protein in Pigs.
    Li D; Xu D; Wang Z; Du Q; Chang L; Zhao X; Huang Y; Tong D
    Viral Immunol; 2017 Mar; 30(2):111-119. PubMed ID: 27996636
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Heterologous Viral Protein Scaffold for Chimeric Antigen Design: An Example PCV2 Virus Vaccine Candidate.
    Lamazares E; Gutiérrez F; Hidalgo A; Gutiérrez NA; Espinoza FI; Sánchez O; Cortez-San Martín M; Mascayano C; González J; Saavedra J; Altamirano C; Mansur M; Ruiz Á; Toledo JR
    Viruses; 2020 Mar; 12(4):. PubMed ID: 32244384
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nanovaccine Confers Dual Protection Against Influenza A Virus And Porcine Circovirus Type 2.
    Ding P; Jin Q; Chen X; Yang S; Guo J; Xing G; Deng R; Wang A; Zhang G
    Int J Nanomedicine; 2019; 14():7533-7548. PubMed ID: 31571862
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of a porcine circovirus type 2a (PCV2a) vaccine efficacy against experimental PCV2a, PCV2b, and PCV2d challenge.
    Park KH; Oh T; Yang S; Cho H; Kang I; Chae C
    Vet Microbiol; 2019 Apr; 231():87-92. PubMed ID: 30955830
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunity Elicited by an Experimental Vaccine Based on Recombinant Flagellin-Porcine Circovirus Type 2 Cap Fusion Protein in Piglets.
    Zhu S; Zhang C; Wang J; Wei L; Quan R; Yang J; Yan X; Li Z; She R; Hu F; Liu J
    PLoS One; 2016; 11(2):e0147432. PubMed ID: 26848967
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Porcine circovirus type 2a or 2b based experimental vaccines provide protection against PCV2d/porcine parvovirus 2 co-challenge.
    Opriessnig T; Karuppannan AK; Halbur PG; Calvert JG; Nitzel GP; Matzinger SR; Meng XJ
    Vaccine; 2020 Feb; 38(8):1975-1981. PubMed ID: 31974016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhancement of the immunogenicity of a porcine circovirus type 2 DNA vaccine by a recombinant plasmid coexpressing capsid protein and porcine interleukin-6 in mice.
    Guo XQ; Wang LQ; Qiao H; Yang XW; Yang MF; Chen HY
    Microbiol Immunol; 2015 Mar; 59(3):174-80. PubMed ID: 25664504
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunogenicity of adenovirus vaccines expressing the PCV2 capsid protein in pigs.
    Li D; Du Q; Wu B; Li J; Chang L; Zhao X; Huang Y; Tong D
    Vaccine; 2017 Aug; 35(36):4722-4729. PubMed ID: 28755834
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural roles of PCV2 capsid protein N-terminus in PCV2 particle assembly and identification of PCV2 type-specific neutralizing epitope.
    Mo X; Li X; Yin B; Deng J; Tian K; Yuan A
    PLoS Pathog; 2019 Mar; 15(3):e1007562. PubMed ID: 30822338
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heterologous expression of full-length capsid protein of porcine circovirus 2 in Escherichia coli and its potential use for detection of antibodies.
    Marcekova Z; Psikal I; Kosinova E; Benada O; Sebo P; Bumba L
    J Virol Methods; 2009 Dec; 162(1-2):133-41. PubMed ID: 19664658
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protective humoral immunity in guinea pigs induced by PCV2 virus-like particles displaying the B cell linear epitope (
    Wang N; Zhang S; Wang D; Li F; Liang L; Li X; Zou Y; Zhan Y; Chen G; Yu W; Deng Z; Tu D; Cui S
    Vet Microbiol; 2019 Aug; 235():86-92. PubMed ID: 31282383
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protective immunity conferred by porcine circovirus 2 ORF2-based DNA vaccine in mice.
    Sylla S; Cong YL; Sun YX; Yang GL; Ding XM; Yang ZQ; Zhou YL; Yang M; Wang CF; Ding Z
    Microbiol Immunol; 2014 Jul; 58(7):398-408. PubMed ID: 24845706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.